REN and metabolic syndrome: The pathophysiological interaction between hypertension and dyslipidemia, which includes oxidative stress, proinflammatory activities, renin–angiotensin–aldosterone system activation, and endothelial dysfunction, has been supported by accumulating evidence (42).